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Abstract 
 
In this paper, we had analyzed a large scale Diabetic data sets for several patients to find the length of time 
taken for treatment for each class of Diabetes and the risk of re-admission of diabetic patients performing 
Bigdata analytics, the type of diabetes and its outcome which acted as a high risk sample of patient data sets. We 
have collected and integrated different sources of diabetic information for several patients, from primary and 
secondary treatment information to administrative information, to analyze novel view of patient care processes 
such as type of treatments and every patient behaviors on which results multifaceted nature of chronic care that 
we take into our account to predict the survival factors and length of stay. Nowadays by using electronic 
medical equipments with high quality and high degree calibrations, we are able to gather large amounts of real-
time diabetic data sets.  The requires the usage of distributed platforms for making BigData analysis that results 
on making decisions based on available data and its trends.  This type of Bigdata analysis allows geographical 
and environmental information of patients' enables the capability of interpreting the ethnicity of data gathered 
and extract new analysis to identify survival options and treatment timelines (LOS) from them. 
 
 
1.Introduction 
Diabetes is becoming a potential epidemic in India with more than 62 million individuals currently diagnosed 
with the disease[1]. It is a troubling reality, that this disease will continue to be a prevalent problem in India and 
throughout the world.[2] 
       India with 31.7 million diabetic individuals, topped the world with the highest number of people with 
diabetes mellitus in the year 2000, followed by China with 20.8 million individuals along with the United States 
having 17.7 million in second and third place respectively. According to Wild et al.[3] there will be an increase 
in diabetes is predicted to double globally from 171 million in 2000 to 366 million in 2030 with a maximum 
increase in India.  Many external influences affect the development of disease throughout a country, and 
identification of those factors is necessary to facilitate change when facing the challenges in treating them.  For 
a given time period, the individuals may have high or low symptoms which leads for revisiting for treatment.  A 
class of diabetes for a particular ethnicity is could be cured on a time span. 
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      We had implemented a model to identify high risk of readmission through Bigdata analytics that enables 
high opportunity with accessibility to healthcare providers based on factual data that facilitates them to develop 
programs to improve the quality of treatments. The proper implementation of these analytic methods over large-
scale data would enable proper utilization of resources in hospitals thus reduces the readmission rate and the 
cost incurred due to re-hospitalization. The evolution of predictive modelling solutions are challenging for 
identifying patient’s survival and risks of readmission in healthcare informatics and for computing the treatment 
timelines. 
      Analysis were performed and created using factual patient data sets from medical equipments and the 
quantified values on physical examination which acted as structured data. There is a significant increase in the 
digital  calibrations from electronic devices and growing volume of medical and patient data sets, over the last 
ten years accelerated the need for efficient tools to analyse the large data for computation and analytical 
processing technologies. Big Data includes new data management systems, improved analytics capabilities, 
faster hardware which facilitates faster predictability, access through all data sets and efficient result generation. 
2.Big data analysis methodology on Diabetic data 
 
2.1.Large scale diabetic health-care data sets 
 
Clinical data sets from hospital databases contains valuable but heterogeneous and difficult data in terms of 
missing values, incomplete  information or inconsistent records for each patients[4].  It's high dimensionality 
depends upon the number of disease parameters and their number of features but also their complexity. 
Analyzing external factual data is more challenging than that of analysis of results of a carefully designed 
experiment or trial.  Because one does not know on how and what type of information was collected. So, we 
carefully performed our analysis by knowing, it is very important to use these huge amounts of data wherever 
needed, to find new information that could be possibly not available or difficult to predict anywhere. 
 
2.2.Data Assembly 
 
This study used the patient data sets for 195 diabetic individuals as a comprehensive clinical records across 
various hospitals throughout Chennai and Kanchipuram, India. The Health Facts data we used was an extract of 
a random samples of patients, representing 5 years (2011–2016) of clinical care at 12 hospitals.  This data 
represents stand-alone hospitals, the data contains both inpatient and outpatient data, including emergency 
department, for the same and other group of diabetic patients. 
 
2.3. Identification of initial knowledge on existing data set 
 
(1) We identified inpatient encounters where a patient is treated under a hospital admission. 
(2) We identified “diabetic” encounter, where we grouped patients where diabetes was entered to the system as 
adiagnosis. 
(3) We grouped the patients with length of stay was at least 1 day and at most 14 days. 
(4) We gathered the results of laboratory tests were performed during the encounter for few parameters. 
(5) We considered the type of medications were administered during the encounter. 
 
We then identified the random samples which were of less than 23 hrs of duration.  In which we observed, 
changes in diabetes management were less likely to have occurred. We noted that the diabetic encounters are not 
all encounters of diabetic patients but rather only these encounters where diabetes was coded as an existing 
health condition.  Based on age and gender factors we are predicting the survival of patients and their length of 
stay for treatment.  
 
3.Types of Diabetes 
 
Type 1 –  The pancreatic cells that generates insulin have been destroyed by the immune system of the 
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body. There is a need of injections of insulin along with frequent blood tests and dietary restrictions for patients 
having  Type 1 diabetes. 
 
Type 2 – Adult-onset diabetes or the non-insulin dependent diabetes. Various organs of the body become resistant 
to insulin which increases the demand for insulin. Pancreas doesn’t make the required amount of insulin. Most of 
Type 2 diabetes patients have border line diabetes where the blood glucose levels are higher than normal but not 
as high as a 
diabetic patient. 
 
Gestational diabetes – Occur in pregnant women due to the high sugar levels as the pancreas don’t produce 
sufficient amount of insulin. Taking no treatment could create complications during childbirth. Diet control and 
taking insulin can control this form of diabetes 
 
3.1 Symptoms and Treatment: 
 
The common symptoms of a person suffering from diabetes are: 
 
• Polyuria (frequent urination) 
• Polyphagia (excessive hunger) 
• Polydipsia (excessive thirst) 
• Weight gain or strange weight loss 
• Healing of wounds is not quick, blurred vision, fatigue, itchy skin, etc. 
 
Detection of diabetes is done based on results of urine test and blood tests by checking for excess body glucose. 
Commonly conducted tests: 
 
• A1C Test 
• Fasting Plasma Glucose (FPG) Test 
• Oral Glucose Tolerance Test (OGTT). 
 
4.Analysis Methodology on diabetic data 
 
We are considering the parameters mentioned below; 
1. Number of times pregnant  
2. Plasma glucose concentration a  hours in an oral glucose tolerance test  
3. Diastolic blood pressure (mm Hg)  
4. Triceps skin fold thickness (mm)  
5. Hour Serum insulin (mu U/ml)  
6. Body mass index (weight in kg/(height inm))  
7. Diabetes pedigree function  
8. Age (years) 
4.1 Prediction models: 
 
     We are using multivariate quantitative statistical method which uses dependent variable along with multiple 
independent variables.  We have made observations on the effects of patients and hospital characteristics on the 
diabetic in patients. 
 
4.1.1 Power analysis: 
 
         For the given set of patient data, we are observing the study has sufficient power >=0.795.  We are further 
querying to identify the co-morbidities of diabetes and the behavior of patient among the types of diabetes. 
 
4.1.2 Statistical Analysis: 
 
       Patient’s basic characteristics such as Age, Gender, type of diabetes with all other available characteristics 
were compared.  Chi-square, independent t-tests and ANOVA were used to detect the actual differences 
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between the actual outcomes and patients with the data analysis results that include, gender, length of stay, 
transfer of patients and death.  Multivariate analysis for these predictors were used to determine the effect of our 
result of our prediction and its accuracy. 
      The frequency analysis resulted that more males were admitted in hospital than that of females.  The 
majority of them have poor food habits and have hypertension.  This can be corrected to have more survival 
time of these types of patients.  The mean age of all patients was 63.72 (SD+- 13.33).  Many of these patients 
were admitted through an emergency.  Most of the secondary diagnosis were ranged from coronary 
atherosclerosis (,20%) to paroxysmal ventricular tachycardia(3.4%) which includes cardiogenic shock (1.4%) to 
hypotension (0.3%).  We have presented the patient characteristics in Table 1 given below. 
 
Admission Type Emergency 66% 
 Urgent 25% 
 Elective 8% 
 Other  0% 
Length of Stay (Days) 0-12 7.7% 
 13-25 13.1% 
 26-38 16.1% 
 39-51 11.7% 
 52-64 7.9% 
 65-77 5.9% 
 Other 38.6% 
Hospital transfer Routine 62.8 
 Transfer to short term hospital 9.8% 
 Transfer to home care (Discharge) 10.2% 
 Against Medical advice 0.7% 
 Died in hospital 7.1% 
 Died during hospitalization 7.2% 
Table 1: Characteristic parameters of diabetic patients 
 
4.1.3 Bivariate analysis on Length of stay and Patient’s age 
 
     This shows that the patient’s age is having impact on length of stay in hospital.  Bonferroni post hoc tests 
were significant for patients for which we have presented the Mean and SD in the table 2 and table 3 below. The 
results shows that the older patients’ LOS is higher than that of younger diabetic patients. 
 
Age Group Mean SD 
33-45 (p=0.004) 3.44 3.99 
46-58 3.89 4.12 
72-84 (p=0.002) 4.80 5.04 
Table 2: Mean and SD for highly significant age groups 
 
Age Group Mean Difference  P 
20-32 33-45 -1.938 1.000 
46-58 -2.388 0.813 
59-71 -2.811 0.401 
72-84 -3.296 0.163 
33.45 20-32 1.938 1.000 
46-58 -0.451 1.000 
59-71 -0.874 0.199 
72-84 -1.358* 0.004 
46-58 20-32 2.388 0.813 
33-45 0.451 1.000 
46-58 0.423 0.677 
72-84 -0.907* 0.002 
59-71 20-32 2.811 0.401 
33.45 0.874 0.199 
46-58 0.423 0.677 
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72-84 -0.484 0.433 
>=72 20-32 3.296 0.163 
 33-45 1.358* 0.004 
 46-58 0.907* 0.002 
 59-71 0.484 0.433 
Table 3: Mean and difference for LOS for all age group sample set  
 
4.1.4 Multivariate analysis on impacts of dependent variables on length of stay (LOS): 
 
     We are observing, the patients having other diseases (such as cardiac diseases) in addition to Type 2 diabetes 
stayed longer in hospital or have significantly higher treatment time range than that of other patients having only 
diabetes variations as a result of their pre-existing disease condition as mentioned in Table 4.  These patients 
with complications on diabetes have lesser survival time. 
 
Variable B Std.Error Beta t p 
Gender 0.931 0.193 0.092 4.827 0.000 
Age 0.039 0.008 0.113 4.794 0.000 
Coronary 
Atherosclerosis 
-1.312 0.226 -1.110 -5.797 0.000 
Hypertension -2.080 0.483 -0.080 -4.309 0.000 
Adjustment. R2=-.092, p<0.001 
Table 4: Multivariate analysis on primary factors of diabetic patients 
 
5. Discussion 
     Age and Gender have significant dependence of survival time.  These factor determines the difference in 
survival on any subset of the available covariates.Age, gender and the severity of diabetes with the type of 
treatment are the subsets of the covariates help to explain survival time. For example, age and gender, at time of 
first treatment acts as primary dependant variable to determine the relative risk of survival. Data for each patient 
consists of age at first admission to the hospital, sex, number of years of follow-up (years from admission to death 
or censoring), and patient status at the follow up time. The main goal is to compare the survival experience of 
these patients to the Race or No. of Treatments to determine if patients tend to have shorter lifetimes. We are 
seeing the results few of the patients are not exhibiting the classic symptoms of MI.  They are not treated 
agressively and their conditions are usually complicated with they are diagnosed to MI. Since, the diagnosis 
happens once the disease becomes severe, the survival of  is becoming lesser than men with higher amount of 
treatment and medications. 
 
     Based on analysis, we are observing Men have a more favorable survival experience over time than women. 
compared to men, we are seeing lesser number of women who have admitted.  But we are observing longer length 
of stay.  However, more number of men are admitted / diagnosed for diabetes, treated with lesser length of stay. 
Although MI and Type 2 Diabetes affect all ages, the disease is becoming increasingly prevalent with gender and 
age that shows greatest effect on elderly people.  More than 18% of adults older than 65 have diabetes and the 
majority with Type 2 Diabetes. So, the change of medication on admission or readmission for the patients with 
age <30 will improve the diabetic condition and leads to more survival time than the elderly ones. We are 
observing there were still unexplained variances which we are seeing in this study, that could be the results of 
some independent variables that were not used because of the nature of database used. So, we are still analyzing 
this factor which we will use in our future work. 
 
6. Conclusions 
 
Since diabetes is being considered as one of the top priorities in medical science and health care management.  
The data sets from statistical models or complex pattern recognition models may be fused into a predictive 
models that combines data set of patients' treatment information and prognostic outcome results. This could be 
used in clinical decision support and diabetes surveillance to improve patient care. We are concentrating on 
outcomes over predictive models in screening for and the management of prevalent short term and long term 
complications on this disease. Several Predictive models already have been developed for management of 
diabetes and its complications along with the number of publications on such models has been growing over the 
past decade. We are observing, multiple logistic or a similar linear regression is used for prediction model 
development, possibly owing because of its transparent functionality.  Although extensive effort has been put in 
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to building these predictive models, still there is a remarkable scarcity of impact studies.  Our approach analyzes 
and predicts the outcomes by considering all parameters, since each of them would have significant impact on 
its own. 
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